United States Recombinant Antibody Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Recombinant Antibody Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Recombinant Antibody Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Recombinant Antibody Overall Market Size
2.1 United States Recombinant Antibody Market Size: 2021 VS 2027
2.2 United States Recombinant Antibody Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Recombinant Antibody Players in United States Market
3.2 Top United States Recombinant Antibody Companies Ranked by Revenue
3.3 United States Recombinant Antibody Revenue by Companies
3.4 Top 3 and Top 5 Recombinant Antibody Companies in United States Market, by Revenue in 2020
3.5 Companies Recombinant Antibody Product Type
3.6 Tier 1, Tier 2 and Tier 3 Recombinant Antibody Players in United States Market
3.6.1 List of Tier 1 Recombinant Antibody Companies in United States
3.6.2 List of Tier 2 and Tier 3 Recombinant Antibody Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Recombinant Antibody Market Size Markets, 2021 & 2027
4.1.2 Chimeric Antibody
4.1.3 Humanized Antibody
4.1.4 Full Human Antibody
4.1.5 Single Chain Antibody
4.1.6 Bispecific Antibody
4.2 By Type - United States Recombinant Antibody Revenue & Forecasts
4.2.1 By Type - United States Recombinant Antibody Revenue, 2016-2021
4.2.2 By Type - United States Recombinant Antibody Revenue, 2022-2027
4.2.3 By Type - United States Recombinant Antibody Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Recombinant Antibody Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Scientific Research
5.1.4 Others
5.2 By Application - United States Recombinant Antibody Revenue & Forecasts
5.2.1 By Application - United States Recombinant Antibody Revenue, 2016-2021
5.2.2 By Application - United States Recombinant Antibody Revenue, 2022-2027
5.2.3 By Application - United States Recombinant Antibody Revenue Market Share, 2016-2027
6 Recombinant Antibody Companies Profiles
6.1 Abnova
6.1.1 Abnova Company Details
6.1.2 Abnova Business Overview
6.1.3 Abnova Recombinant Antibody Introduction
6.1.4 Abnova Recombinant Antibody Revenue in United States Market (2016-2021)
6.1.5 Abnova Recent Developments
6.2 Medix Biochemica
6.2.1 Medix Biochemica Company Details
6.2.2 Medix Biochemica Business Overview
6.2.3 Medix Biochemica Recombinant Antibody Introduction
6.2.4 Medix Biochemica Recombinant Antibody Revenue in United States Market (2016-2021)
6.2.5 Medix Biochemica Recent Developments
6.3 GE Healthcare
6.3.1 GE Healthcare Company Details
6.3.2 GE Healthcare Business Overview
6.3.3 GE Healthcare Recombinant Antibody Introduction
6.3.4 GE Healthcare Recombinant Antibody Revenue in United States Market (2016-2021)
6.3.5 GE Healthcare Recent Developments
6.4 SinoBiological
6.4.1 SinoBiological Company Details
6.4.2 SinoBiological Business Overview
6.4.3 SinoBiological Recombinant Antibody Introduction
6.4.4 SinoBiological Recombinant Antibody Revenue in United States Market (2016-2021)
6.4.5 SinoBiological Recent Developments
6.5 Bioventix
6.5.1 Bioventix Company Details
6.5.2 Bioventix Business Overview
6.5.3 Bioventix Recombinant Antibody Introduction
6.5.4 Bioventix Recombinant Antibody Revenue in United States Market (2016-2021)
6.5.5 Bioventix Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of TablesTable 1. Recombinant Antibody Market Opportunities & Trends in United States Market
Table 2. Recombinant Antibody Market Drivers in United States Market
Table 3. Recombinant Antibody Market Restraints in United States Market
Table 4. Key Players of Recombinant Antibody in United States Market
Table 5. Top Recombinant Antibody Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Recombinant Antibody Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Recombinant Antibody Revenue Share by Companies, 2016-2021
Table 8. Companies Recombinant Antibody Product Type
Table 9. List of Tier 1 Recombinant Antibody Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Recombinant Antibody Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Recombinant Antibody Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Recombinant Antibody Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Recombinant Antibody Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Recombinant Antibody Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Recombinant Antibody Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Recombinant Antibody Revenue (US$, Mn), 2022-2027
Table 17. Abnova Company Details
Table 18. Abnova Business Overview
Table 19. Abnova Recombinant Antibody Product
Table 20. Abnova Recombinant Antibody Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Abnova Recent Developments
Table 22. Medix Biochemica Company Details
Table 23. Medix Biochemica Business Overview
Table 24. Medix Biochemica Recombinant Antibody Product
Table 25. Medix Biochemica Recombinant Antibody Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Medix Biochemica Recent Developments
Table 27. GE Healthcare Company Details
Table 28. GE Healthcare Business Overview
Table 29. GE Healthcare Recombinant Antibody Product
Table 30. GE Healthcare Recombinant Antibody Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. GE Healthcare Recent Developments
Table 32. SinoBiological Company Details
Table 33. SinoBiological Business Overview
Table 34. SinoBiological Recombinant Antibody Product
Table 35. SinoBiological Recombinant Antibody Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. SinoBiological Recent Developments
Table 37. Bioventix Company Details
Table 38. Bioventix Business Overview
Table 39. Bioventix Recombinant Antibody Product
Table 40. Bioventix Recombinant Antibody Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Bioventix Recent Developments
List of FiguresFigure 1. Recombinant Antibody Segment by Type
Figure 2. Recombinant Antibody Segment by Application
Figure 3. United States Recombinant Antibody Market Overview: 2020
Figure 4. United States Recombinant Antibody Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Recombinant Antibody Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Recombinant Antibody Revenue in 2020
Figure 7. By Type - United States Recombinant Antibody Revenue Market Share, 2016-2027
Figure 8. By Application - United States Recombinant Antibody Revenue Market Share, 2016-2027
Figure 9. Abnova Recombinant Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Medix Biochemica Recombinant Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. GE Healthcare Recombinant Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. SinoBiological Recombinant Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Bioventix Recombinant Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)